Fish Oil and the Management of Hypertriglyceridemia
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Hypertriglyceridemia, regarded as one of the independent clinical markers of metabolic syndrome, is a frequently observed disorder that has been shown to be common in the Arab region. Epidemiologic and clinical trials demonstrated that omega-3 fatty acids have the potential to reduce the incidence of cardiovascular disease (CVD); one of the mechanisms by which this effect is achieved is through reducing plasma triglyceride levels. There is strong scientific evidence from human trials that omega-3 fatty acids from either fish or fish oil supplements significantly reduce blood triglyceride levels and these benefits appear to be dose-dependent. The active ingredients of fish oils include the long chain fatty acids EPA and DHA. The ideal amount of omega-3 fatty acid that should be incorporated into the diet without provoking detrimental effects on other lipid components such as decreasing HDL-C and/or increasing LDL-C has not yet been elucidated. Presently, a prescription form of omega-3 fatty acid has been approved by the United States Food and Drug Administration (USFDA) as an adjunct to the diet for the treatment of very high triglyceride levels (~ 500 mg/dl) in adults. Patients with hypertriglyceridemia have been shown to respond well to the use of omega-3 fatty acids even when used in conjunction with statins where greater improvements in the lipid profile were found as compared to treatment with statins alone. A determinant of the responsiveness to fish oil could be attributed to the ApoE genotype of individuals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A high monounsaturated fat diet significantly improves insulin sensitivity compared with a high saturated fat diet.84 This goes in parallel with a reduction in TG levels”
From ESC/EAS Guidelines for the management of dyslipidaemias (2011) · cites this paper as [84]
Citations
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease
Kris-Etherton, P. M., Harris, W. S., & Appel, L. J. (2002) · Circulation · doi:10.1161/01.cir.0000038493.65177.94 · Cited by 3,707
Role of oxidized low density lipoprotein in atherogenesis.
Witztum, J. L., & Steinberg, D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115499 · Cited by 2,675
Importance of n−3 fatty acids in health and disease
Connor, W. E. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.1.171s · Cited by 1,344
n-3 fatty acids and serum lipoproteins: human studies
Harris, W. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.5.1645s · Cited by 1,243
Lauritzen, L. (2001) · Progress in Lipid Research · doi:10.1016/s0163-7827(00)00017-5 · Cited by 1,063
Polyunsaturated fatty acids in the food chain in the United States
Kris-Etherton, P., Taylor, D. S., Yu-Poth, S., Huth, P., Moriarty, K., Fishell, V., Hargrove, R. L., Zhao, G., & Etherton, T. D. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.1.179s · Cited by 1,023
Hypertriglyceridemia: its etiology, effects and treatment
Yuan, G., Al-Shali, K. Z., & Hegele, R. A. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.060963 · Cited by 624
Physiological compartmental analysis of α-linolenic acid metabolism in adult humans
Pawlosky, R. J., Hibbeln, J. R., Novotny, J. A., & Salem, N. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31576-5 · Cited by 592
Mori, T. A., Burke, V., Puddey, I. B., Watts, G. F., O’Neal, D. N., Best, J. D., & Beilin, L. J. (2000) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.5.1085 · Cited by 588
Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives
Harris, W. S., Miller, M., Tighe, A. P., Davidson, M. H., & Schaefer, E. J. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.11.008 · Cited by 552
Cases of mercury exposure, bioavailability, and absorption
Gochfeld, M. (2003) · Ecotoxicology and Environmental Safety · doi:10.1016/s0147-6513(03)00060-5 · Cited by 485
Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis.
Dallongeville, J., Lussier-Cacan, S., & Davignon, J. (1992) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41611-6 · Cited by 448
Goyens, P. L., Spilker, M. E., Zock, P. L., Katan, M. B., & Mensink, R. P. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.1.44 · Cited by 392
Mechanisms for the Hypotriglyceridemic Effect of Marine Omega-3 Fatty Acids
Davidson, M. H. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.024 · Cited by 374
APOE distribution in world populations with new data from India and the UK
Singh, P. P., Singh, M., & Mastana, S. S. (2006) · Annals of Human Biology · doi:10.1080/03014460600594513 · Cited by 351
Sanders, T. A. B., & Roshanai, F. (1983) · Clinical Science · doi:10.1042/cs0640091 · Cited by 308
Prevalence of the Metabolic Syndrome Among Omani Adults
Al-Lawati, J. A., Mohammed, A. J., Al-Hinai, H. Q., & Jousilahti, P. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1781 · Cited by 267
ApoE Polymorphism and Fish Oil Supplementation in Subjects With an Atherogenic Lipoprotein Phenotype
Minihane, A. M., Khan, S., Leigh-Firbank, E. C., Talmud, P., Wright, J. W., Murphy, M. C., Griffin, B. A., & Williams, C. M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.8.1990 · Cited by 215
Suzukawa, M., Abbey, M., Howe, P. R., & Nestel, P. J. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39881-3 · Cited by 185
Metabolic syndrome in Saudi Arabia
Al-Nozha, M. M., Al-Khadra, A. H., Arafah, M., Al-Maatouq, M. A., Khalil, M. Z., Khan, N. B., Al-Mazrou, Y. Y., Al-Marzouki, K., Al-Harthi, S. S., Abdullah, M., et al. (2005) · Saudi Medical Journal · doi:10.15537/1658-3175.3235 · Cited by 158
Pejic, R. N., & Lee, D. T. (2006) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.19.3.310 · Cited by 122
Buckley, R., Shewring, B., Turner, R., Yaqoob, P., & Minihane, A. M. (2004) · British Journal of Nutrition · doi:10.1079/bjn20041235 · Cited by 118
Indu, M. S., & Ghafoorunissa (1992) · Nutrition Research · doi:10.1016/s0271-5317(05)80027-2 · Cited by 107
Prescription omega-3 fatty acids for the treatment of hypertriglyceridemia
McKenney, J. M., & Sica, D. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060164 · Cited by 95
High prevalence of the metabolic syndrome among Northern Jordanians
Khader, Y. S., Batieha, A. M., El-Khateeb, M. S., Alshaikh, A. A., & Ajlouni, K. M. (2007) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2005.11.003 · Cited by 94
Oily fish reduces plasma triacylglycerols: a primary prevention study in overweight men and women
Moore, C. S., Bryant, S. P., Mishra, G. D., Krebs, J. D., Browning, L. M., Miller, G. J., & Jebb, S. A. (2006) · Nutrition · doi:10.1016/j.nut.2006.07.005 · Cited by 86
Damsgaard, C. T., Frøkiær, H., Andersen, A. D., & Lauritzen, L. (2008) · Journal of Nutrition · doi:10.1093/jn/138.6.1061 · Cited by 75
Prevalence and correlates of metabolic syndrome in an adult Lebanese population
Sibai, A. M., Obeid, O., Batal, M., Adra, N., Khoury, D. T. D. E., & Hwalla, N. C. (2008) · Global Heart · doi:10.1016/j.precon.2007.06.002 · Cited by 73
Self-citationFatty Acid Consumption and Metabolic Syndrome Components: The GOCADAN Study
Ebbesson, S. O. E., Tejero, M. E., Nobmann, E. D., Lopez‐Alvarenga, J. C., Ebbesson, L., Romenesko, T., Carter, E. A., Resnick, H. E., Devereux, R. B., MacCluer, J. W., et al. (2007) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4564.2007.07393.x · Cited by 64
Prevalence of metabolic abnormalities in the Tunisian adults: a population based study
Bouguerra, R., Salem, L. B., Alberti, H., Rayana, C. B., Atti, J. E., Blouza, S., Gaigi, S., Achour, A., Slama, C. B., & Zouari, B. (2006) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70271-9 · Cited by 53
Omega-3 polyunsaturated fatty acids in adolescents: knowledge and consumption
Harel, Z., Riggs, S., Vaz, R. M., White, L., & Menzies, G. (2001) · Journal of Adolescent Health · doi:10.1016/s1054-139x(00)00179-8 · Cited by 51
Adipose tissue triglyceride fatty acids and atherosclerosis in Alaska Natives and non-Natives
McLaughlin, J., Middaugh, J. P., Boudreau, D. A., Malcom, G. T., Parry, S., Tracy, R. E., & Newman, W. P. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.01.019 · Cited by 39
Sorkhou, E., Al-Qallaf, B., Al-Namash, H., Ben-Nakhi, A., El-Batish, M., & Habiba, S. (2003) · Medical Principles and Practice · doi:10.1159/000074050 · Cited by 32
Fish Oil Supplementation Versus Gemfibrozil Treatment in Hyperlipidemic NIDDM
Fasching, P., Rohac, M., Liener, K., Schneider, B., Nowotny, P., & Waldhäusl, W. (1996) · Hormone and Metabolic Research · doi:10.1055/s-2007-979171 · Cited by 14
Effect of Combination Lipid-Modifying Therapy on the Triglyceride Lowering Effect of Fish Oil
Aligeti, V. R., Gandhi, M., Elam, M. B., Braden, R., & Rezk, A. (2007) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3180312ebf · Cited by 7
Research works printed but not linked: 4
- Al-Nozha M., 2005, Saudi Med J., 26, 1918
- Ebbesson S.O.E, 2007, JCMS., 2, 244
- GISSI-Prevenzione Trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico, 1999, Lancet, 7, 447
- Mori T.A., 2000, Best
Cited by
ESC/EAS Guidelines for the management of dyslipidaemias
Reiner, Ž., Catapano, A. L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr158 · Cited by 3,549
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw272 · Cited by 3,162
ESC/EAS Guidelines for the management of dyslipidaemias
Catapano, A. L., Reiner, Ž., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.028 · Cited by 706
The differential effects of EPA and DHA on cardiovascular risk factors
Cottin, S. C., Sanders, T. A., & Hall, W. L. (2011) · Proceedings of the Nutrition Society · doi:10.1017/s0029665111000061 · Cited by 247
“There is strong evidence from epidemiological and intervention studies that EPA + DHA consumption decreases TAG levels (22) , thus improving cardiovascular health, and this appears to be dose-dependent (23) .”
Ácidos graxos poli-insaturados n-3 e n-6: metabolismo em mamíferos e resposta imune
Perini, J. A. L., Stevanato, F. B., Sargi, S. C., Visentainer, J. E. L., Dalálio, M. M. D. O., Matshushita, M., de Souza, N. E., & Visentainer, J. V. (2010) · Revista de Nutrição · doi:10.1590/s1415-52732010000600013 · Cited by 205
Metadata
- Authors
- Mattar, M., & Obeid, O.
- Affiliations
- Department of Nutrition and Food Science, American University of Beirut
- American University of Beirut (LB)
- ORCID
- Obeid, Omar
- Venue
- Nutrition and Health
- Publisher
- SAGE Publications
- Published
- 2009-01
- Volume
- 20
- Issue
- 1
- Pages
- 41-49
- ISSN
- 0260-1060 (ISSN-L)
- 2047-945X
- OpenAlex
- W1967898165
- Cited by
- 43
- References
- 38
- Citations by year
- 2025: 1 · 2023: 4 · 2020: 2 · 2019: 1 · 2018: 4 · 2016: 2 · 2015: 1 · 2014: 3 · 2013: 4 · 2012: 2
- FWCI
- 0.76
- Type
- journal article
- Language
- en
- Open access
- diamond
- scholarworks.aub.edu.lb
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Nutrition and Health (publishedVersion)
- PubMed (publishedVersion)
- Scopus
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- hypertriglyceridemia, fish oil, omega-3 fatty acids, EPA, docosahexaenoic acid, triglyceride lowering, metabolic syndrome, cardiovascular disease prevention, statin combination therapy, APOE genotype, lipid profile
- MeSH terms
- Hypolipidemic Agents, Consumer Product Safety, Dose-Response Relationship, Drug, Fish Oils, Humans, Triglycerides, Hypertriglyceridemia, Fatty Acids, Omega-3, Dietary Supplements, Food, Organic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.